Related Experiment Video
Updated: Feb 7, 2026

Author Spotlight: Expression and Purification of Human Solute Carrier Transporters Using Codon-Optimized Genes
Published on: September 29, 2023
Strategies to Reduce Solute Carrier-Mediated Toxicity
1Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
Drug transporters significantly impact drug toxicity by controlling accumulation. Understanding these mechanisms offers strategies to reduce adverse drug effects during clinical use.
Area of Science:
- Pharmacology
- Biochemistry
- Toxicology
Background:
- Drug toxicity is a major clinical concern.
- Transporter proteins play a key role in regulating drug accumulation and subsequent toxicity.
- Existing knowledge highlights the need for strategies to mitigate transporter-mediated adverse effects.
Purpose of the Study:
- To explore the potential for diminishing drug toxicities.
- To investigate how understanding drug disposition by transporters can alleviate adverse effects.
- To review current strategies in managing transporter-mediated toxicity.
Main Methods:
- Review of existing literature on drug transporters and toxicity.
- Analysis of case studies demonstrating the role of transporters in drug disposition.
- Mechanistic evaluation of how transporter function influences drug accumulation and toxicity.
Main Results:
- Transporter proteins are critical regulators of drug accumulation in tissues.
- Alleviating transporter-mediated toxic effects is achievable through strategic interventions.
- Early examples show promise in applying mechanistic insights to reduce drug toxicity.
Conclusions:
- Understanding drug transporter function is crucial for managing clinical drug toxicity.
- Targeting drug transporters offers a viable strategy to reduce adverse drug effects.
- Further research into transporter-mediated disposition is essential for improving drug safety.
More Related Videos
09:47Author Spotlight: Utilizing Next-Generation Polymerized Human Hemoglobin for Improved Donor Lung Evaluation and Preservation in Rats
Published on: June 14, 2024
08:22CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
Published on: March 12, 2018
Related Concept Videos
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Electron Carriers
Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Electrolyte and Nonelectrolyte Solutions
Carrier Transport
Drift Current:
The drift of charge carriers is started by an external electric field (E). Charged particles, such as electrons and holes, experience an acceleration between collisions with lattice atoms. For electrons, this results in a drift velocity (vd) given by:
The ADP/ATP Carrier Protein